Zobrazeno 1 - 10
of 367
pro vyhledávání: ''
Publikováno v:
Leuk Lymphoma
Relapsed/refractory Primary Central Nervous System Lymphoma (R/R PCNSL) has a poor prognosis with no established preferred treatment. We report the efficacy and toxicity of a combination chemotherapy regimen: methotrexate, carmustine, etoposide, and
Publikováno v:
Leukemia & Lymphoma. 61:2998-3001
Prophylactic use of granulocyte colony-stimulating factors (G-CSFs) reduces the risk of febrile neutropenia (FN) and is indicated for high-risk patients, such as elderly patients with B-cell non-Ho...
Autor:
Ronit Gurion, Uri Rozovski, Uri Abadi, Pia Raanani, Lee Peled, Martin Ellis, Pnina Rotman-Pikielny
Publikováno v:
Leukemia & Lymphoma. 60:2922-2926
The reported prevalence of hypercalcemia at diagnosis in non-Hodgkin-lymphoma ranges between 1.3% and 7.4%. These studies included all patients, regardless of lymphoma subtype. We performed a retrospective case-control study to determine the prevalen
Publikováno v:
Leukemia & Lymphoma. 60:2927-2930
Peripheral T-cell lymphoma (PTCL) and cutaneous T-cell lymphoma (CTCL) are rare, heterogeneous non-Hodgkin lymphomas with poor prognoses. Pralatrexate has demonstrated efficacy in T-cell lymphomas; however, mucositis has been reported as the most com
Autor:
Labrador, Jorge, Luno, Elisa, Vellenga, Edo, Brunet, Salut, Gonzalez-Campose, Jose, Chillon, Maria C., Holowiecka, Aleksandra, Esteve, Jordi, Bergua, Juan, Gonzalez-Sanmiguel, Jose D., Gil, Cristina, Tormo, M., Salamero, Olga, Manso, Felix, Fernandez, Isolda, de laSerna, Javier, Moreno, Maria-Jose, Perez-Encinas, M., Krsnik, Isabel, Ribera, Josep-Maria, Cervera, Jose, Calasanz, Maria J., Boluda, Blanca, Sobas, Marta, Lowenberg, Bob, Sanz, Miguel A., Montesinos, Pau, Palmer, L., Fernandez, Ciarlo, S., Bezares, F., Rojas, F., Longoni, H., Gelemur, M., Fazio, P., Canepa, C., Saba, S., Balladares, G., Negri, P., Giunta, M., Milone, J., Prates, M., Lafalse, D., Sossa, C., Jaramillo, F., Mayer, J., Ramos, F., Martinez, J., de Groot, M. R., Schouten, H. C.
Publikováno v:
LEUKEMIA & LYMPHOMA
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Leukemia & Lymphoma, 60(5), 1146-1155. Informa Healthcare
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Leukemia & Lymphoma, 60(5), 1146-1155. TAYLOR & FRANCIS LTD
Leukemia & Lymphoma, 60(5), 1146-1155. Routledge/Taylor & Francis Group
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Leukemia & Lymphoma, 60(5), 1146-1155. Informa Healthcare
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Leukemia & Lymphoma, 60(5), 1146-1155. TAYLOR & FRANCIS LTD
Leukemia & Lymphoma, 60(5), 1146-1155. Routledge/Taylor & Francis Group
Although additional cytogenetic abnormalities (ACA) do not affect the prognosis of patients with t(15;17) acute promyelocytic leukemia (APL), the role of a complex karyotype (CK) is yet to be clarified. We aimed to investigate the relationship of CK
Autor:
Sobas, Marta, Montesinos, Pau, Boluda, Blanca, Bernal, Teresa, Vellenga, Edo, Nomdedeu, Josep, Gonzalez-Campos, Jose, Chillon, Maria, Holowiecka, Aleksandra, Esteve, Jordi, Bergua, Juan, David Gonzalez-Sanmiguel, Jose, Gil-Cortes, Cristina, Tormo, M., Salamero, Olga, Manso, Felix, Fernandez, Isolda, de la Serna, Javier, Moreno, Maria-Jose, Perez-Encinas, Manuel, Krsnik, Isabel, Ribera, Josep-Maria, Escoda, Lourdes, Lowenberg, Bob, Angel Sanz, Miguel, Beltran de Heredia, J. M., Hernandez, J. M., Arias, J., Ramos, F., Roman, A., de la Serna, J., Negri, S., Rayon, C., Esteve, J., Fernandez-Calvo, F. J., Diaz-Mediavilla, J., Gil, C., Olave, M., Amutio, E., Pedro, C., Gorosquieta, A., Viguria, M., Zudaire, M., Molero, T., Sayas, M. J., Guardia, R., Martinez, J., de Groot, M. R., Schouten, H. C.
Publikováno v:
Leukemia & Lymphoma, 60(4), 1030-1035. Informa Healthcare
Leukemia & Lymphoma, 60(4), 1030-1035. TAYLOR & FRANCIS LTD
Leukemia & Lymphoma, 60(4), 1030-1035. Routledge/Taylor & Francis Group
Leukemia & Lymphoma, 60(4), 1030-1035. TAYLOR & FRANCIS LTD
Leukemia & Lymphoma, 60(4), 1030-1035. Routledge/Taylor & Francis Group
Out of 956, there were 95 (10%) CD56+ APL patients treated with PETHEMA ATRA and chemotherapy. CD56+ expression was associated with high WBC, BCR3 isoform, and co-expression of CD2, CD34, CD7, HLA-DR, CD15, and CD117 antigens. CD56+ vs CD56- APL pres
Autor:
Steven M. Devine, Christina Matthews, Marcin Puto, Junan Li, Yvonne A. Efebera, Filiz Yucebay, Julianna Roddy, Basem M. William, Samantha Jaglowski, Don M. Benson, Sam Penza, Sumithira Vasu, Leslie A. Andritsos
Publikováno v:
Leukemia & Lymphoma. 60:2223-2229
Acute graft-versus-host-disease (aGVHD) is a complication after allogeneic stem cell transplant. After the failure of treatment with high dose corticosteroids, steroid-refractory aGVHD (SR aGVHD) is associated with high rates of mortality. Tocilizuma
Autor:
Xinping Zhou, Chao Hu, Liya Ma, Hongyan Tong, Huifang Jiang, Li Ye, Yanling Ren, Chen Mei, Jie Jin, Peipei Lin, Yingwan Luo, Weilai Xu, Fangjing Shi
Publikováno v:
Leukemia & Lymphoma. 60:1731-1739
We retrospectively studied 133 myelodysplastic syndrome patients receiving decitabine during January 2009 and September 2017. The dose of 15 mg/m2/d (n = 83) and 20 mg/m2/d (n = 50) had comparable overall response rates (ORR) (51.8% vs. 52.00%) and c
Autor:
Michael Roost Clausen, Alexander Lindholm d'Amore, Peter Kamper, Maja D. Andersen, Francesco d'Amore, Hans Bentzen
Publikováno v:
Andersen, M D, Kamper, P, d’Amore, A, Clausen, M, Bentzen, H & d'Amore, F 2018, ' The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor † ', Leukemia and Lymphoma . https://doi.org/10.1080/10428194.2018.1515939
In Hodgkin lymphoma (HL) bleomycin can induce pulmonary toxicity (BPT). BPT consists of respiratory tract symptoms during bleomycin-exposure and radiologic pulmonary lesions without concomitant infection. Older age, bleomycin dose, smoking history an
Autor:
Hubert H. Chuang, Chelsea C. Pinnix, Donald Hancock, N. George Mikhaeel, Sarah A. Milgrom, Andrew Wirth, Michalis Aristophanous, Mary Pham, Loretta J. Nastoupil, Bouthaina S. Dabaja, Yasuhiro Oki, Ethan B. Ludmir, Michelle A. Fanale, T.Y. Andraos, Jillian R. Gunther
Publikováno v:
Leukemia & Lymphoma. 59:2650-2659
Cardiophrenic lymph nodes (CPLNs) are occasionally involved in Hodgkin lymphoma (HL). We characterized the incidence of CPLN involvement among 169 HL patients and evaluated outcomes after treatment with omission of the CPLN region from the involved-s